Diagnosing antimicrobial resistance

Nature Reviews Microbiology

Volumn 15, Issue 11, 2017, Pages 697-703

  Burnham, Carey Ann D ^a   Leeds, Jennifer ^b   Nordmann, Patrice ^c   O'Grady, Justin ^d   Patel, Jean ^e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF FRIBOURG   (Switzerland)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; DIAGNOSTIC PROCEDURE; DRUG INDUSTRY; DRUG USE; GENOTYPING TECHNIQUE; GLOBAL HEALTH; HUMAN; INFECTIOUS AGENT; LABORATORY; MEDICAL SOCIETY; MICROBIOLOGY; NONHUMAN; PARAMETERS; PHENOTYPE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RAPID TEST; REVIEW; TURNAROUND TIME; BACTERIAL INFECTIONS; BACTERIUM; CLASSIFICATION; DRUG EFFECTS; ISOLATION AND PURIFICATION; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS;

EID: 85031280270     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2017.103     Document Type: Review

References (11)

1. Kuti, E. L., Patel, A. A., & Coleman, C. I. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-Associated pneumonia and blood stream infection: A meta-Analysis. J. Crit. Care 23, 91-100 (2008
2. Doern, G. V., & Brecher, S. M. The clinical predictive value (or lack thereof) of the results of in vitro antimicrobial susceptibility tests. J. Clin. Microbiol. 49, S11-S14 (2011
3. Clinical and Laboratory Standards Institute. Development of in vitro Susceptibility Testing Criteria and Quality Control Parameters. 4th edn (CLSI, 2008
4. Kircher, S. M., et al. The Susceptibility Testing Manufacturers Association presents an opinion for the delay of current susceptibility tests. Clin. Infect. Dis. 63, 1531-1532 (2016
5. Kahlmeter, G., Åhman, J., & Matuschek, E. Antimicrobial resistance of Escherichia coli causing uncomplicated urinary tract infections: A European update for 2014 and comparison with 2000 and 2008. Infect. Dis. Ther. 4, 417-423 (2015
6. Public Health England. Surveillance of antimicrobial resistance in Neisseria gonorrhoeae: key findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP). GOV. UK https://www.gov.uk/.government/uploads/system/uploads/attachment-data/.file/567602/GRASP-Report-2016.pdf (2016
7. Accelerate Diagnostics. Accelerate Pheno system. Accelerate Diagnostics http://acceleratediagnostics.com/.products/accelerate-pheno-system/#features (2017
8. Nather, D. Inside the Pentagon's biotech strike force. STAT News https://www.statnews.com/2015/11/24/.darpa-biotech-infectious-disease/.(2015
9. Schmidt, K., et al. Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing. J. Antimicrob. Chemother. 72, 104-114 (2017
10. US Food and Drug Administration. FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results. FDA https://www.fda.gov/NewsEvents/Newsroom/.PressAnnouncements/ucm543150.htm (2017
11. McHugh, L., et al. A molecular host response assay to discriminate between sepsis and infection-negative systemic inflammation in critically ill patients: discovery and validation in independent cohorts. PLoS Med. 12, e1001916 (2015